Brewin Dolphin Wealth Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 319 |
|
|
2022
Q1 | $3K | Hold |
10
| – | – | ﹤0.01% | 347 |
|
|
2021
Q4 | $4K | Hold |
10
| – | – | ﹤0.01% | 304 |
|
|
2021
Q3 | $2.56K | Hold |
10
| – | – | ﹤0.01% | 325 |
|
|
2021
Q2 | $6.66K | Hold |
10
| – | – | ﹤0.01% | 306 |
|
|
2021
Q1 | $8.68K | Sell |
10
-15
| -60% | -$13K | ﹤0.01% | 288 |
|
|
2020
Q4 | $23.4K | Hold |
25
| – | – | ﹤0.01% | 219 |
|
|
2020
Q3 | $25.9K | Hold |
25
| – | – | ﹤0.01% | 204 |
|
|
2020
Q2 | $25.5K | Hold |
25
| – | – | 0.01% | 196 |
|
|
2020
Q1 | $21.9K | Hold |
25
| – | – | 0.01% | 140 |
|
|
2019
Q4 | $27K | Hold |
25
| – | – | 0.01% | 150 |
|
|
2019
Q3 | $23.3K | Hold |
25
| – | – | 0.01% | 145 |
|
|
2019
Q2 | $28.5K | Hold |
25
| – | – | 0.01% | 138 |
|
|
2019
Q1 | $34.2K | Hold |
25
| – | – | 0.02% | 123 |
|
|
2018
Q4 | $29.2K | Hold |
25
| – | – | 0.02% | 123 |
|
|
2018
Q3 | $38.3K | Hold |
25
| – | – | 0.02% | 120 |
|
|
2018
Q2 | $39.4K | Hold |
25
| – | – | 0.02% | 116 |
|
|
2018
Q1 | $29.1K | Buy |
+25
| New | +$29.1K | 0.02% | 124 |
|